Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mary E. Link"'
Autor:
Mary E. Link, Matthew M. Hsieh, John F. Tisdale, Katherine Roskom, Wynona Coles, Stefan Cordes, Tiffani Taylor, Courtney D. Fitzhugh
Publikováno v:
Blood. 130:1946-1948
Novel curative therapies using genetic transfer of normal globin-producing genes into autologous hematopoietic stem cells (HSCs) are in clinical trials for patients with sickle cell disease (SCD). The percentage of transferred globin necessary to cur
Publikováno v:
Blood Cells Mol Dis
BACKGROUND: Benign ethnic neutropenia (BEN), defined by neutrophil count less than 1·5 k/uL in the absence of other causes, is an asymptomatic condition more commonly observed in individuals of African ancestry. However, the natural history of this
Autor:
Terri H. Wakefield, Eric R. Henry, William A. Eaton, Jeffrey F. Smith, Matthew M. Hsieh, Mary E. Link, Emily B. Dunkelberger, Jeffery L. Miller, James Hofrichter, Troy Cellmer, John F. Tisdale, Dwayne Staton, Belhu B. Metaferia, Garrott W. Christoph, Stacy Jones-Straehle, Quan Li, Sarah Boutom, Erica R. Vass
Publikováno v:
Proceedings of the National Academy of Sciences. 114
Although it has been known for more than 60 years that the cause of sickle cell disease is polymerization of a hemoglobin mutant, hydroxyurea is the only drug approved for treatment by the US Food and Drug Administration. This drug, however, is only
Autor:
John F. Tisdale, Matthew M. Hsieh, Nicola M. Neary, Courtney D. Fitzhugh, Helen Gharwan, Richard J. Sherins, Mary E. Link
Publikováno v:
Endocrine Practice. 20:e157-e161
Objective Myeloablative conditioning regimens given prior to hematopoietic stem cell transplantation (HSCT) frequently cause permanent sterility in men. In patients with sickle cell disease (SCD) we use a nonmyeloablative regimen with sirolimus, alem
Autor:
Alexis Leonard, Aylin C. Bonifacino, Francis J. Pierciey, Anna Conrey, Naoya Uchida, Venina Marcela Dominical, John F. Tisdale, Mary E. Link, Wynona Coles, Min Luo, Matthew M. Hsieh
Publikováno v:
Blood. 130:966-966
Introduction Gene therapy for sickle cell disease (SCD) requires modification of a high number of long term engrafting hematopoietic stem cells (LT-HSCs) sufficient to sustain production of the gene of interest at levels capable of overcoming the pat
Autor:
Elizabeth J. Read, Griffin P. Rodgers, Susan F. Leitman, Virginia David-Ocampo, John F. Tisdale, Mary E. Link, Courtney D. Fitzhugh, Elizabeth M. Kang, Ellen M. Areman
Publikováno v:
Blood. 99:850-855
Mobilized peripheral blood is increasingly used as the source of hematopoietic stem cells for allogeneic transplantation, currently the only curative approach for sickle cell anemia. However, the safety and feasibility of stem cell mobilization in in
Autor:
John F. Tisdale, Wynona Coles, R. Patrick Weitzel, Jonathan D. Powell, Matthew M. Hsieh, Mary E. Link, Xiongce Zhao, Griffin P. Rodgers, Courtney D. Fitzhugh
Publikováno v:
JAMA. 312(1)
Importance Myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) is curative for children with severe sickle cell disease, but toxicity may be prohibitive for adults. Nonmyeloablative transplantation has been attempted with degrees
Autor:
Eugene Park, Mary E. Link, Jay N. Lozier, Chutima Kumkhaek, Tiffani Taylor, John F. Tisdale, Matthew M. Hsieh, Wynona Coles
Publikováno v:
Blood. 128:3842-3842
We have reported a case of acquired hemophilia A in our series of sickle cell disease patients treated with hematopoietic stem cell transplantation (HSCT) using HLA matched sibling donors, non-myeloablative conditioning, and sirolimus immunosuppressi
Publikováno v:
Clinical Nursing Research. 9:479-491
The purpose of this study was to compare two lying and standing procedures for measuring orthostatic vital signs. Thirty-five normotensive participants (mean age 21.6 years) participated in a randomized crossover study. Measures of blood pressure (BP
Autor:
Wynona Coles, John F. Tisdale, Vincent Hathaway, Courtney D. Fitzhugh, Hayato Unno, Xiongce Zhao, Mary E. Link, Elizabeth C. Wright, David F. Stroncek, Gregory J. Kato, Matthew M. Hsieh, R. Patrick Weitzel
Peripheral blood stem cell (PBSC) infusions are associated with complications such as elevated blood pressure and decreased creatinine clearance. Patients with sickle cell disease experience similar manifestations, and some have postulated release of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb1cc4854d84db07e29c416a0e39614
https://europepmc.org/articles/PMC3382927/
https://europepmc.org/articles/PMC3382927/